Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Heard

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Medical Journal of Australia|July 5, 1993
HTLV-I in AustraliaR N Heard
The Medical Journal of Australia|May 17, 1993
New horizons in the treatment of multiple sclerosisR N Heard
International Clinical Psychopharmacology|July 1, 1986
Visual hallucinations due to indomethacin: a case reportL E Braddock, R N Heard
Immunogenetics|January 1, 1989
An epitope on C4 beta light (L) chains detected by human anti-Rg; its relationship with beta chain polymorphism and MHC associationsT Robson, R N Heard, C M Giles
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2000
T cell receptor beta chain genotyping in Australian relapsing-remitting multiple sclerosis patientsM M Buhler, B H Bennetts, R N Heard, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|April 1, 1997
HLA-DR, -DQA1 and -DQB1 associations in Australian multiple sclerosis patientsG J Stewart, S M Teutsch, M Castle, et al.
Journal of Neuroimmunology|June 1, 1995
TAP2 polymorphisms in Australian multiple sclerosis patientsB H Bennetts, S M Teutsch, R N Heard, et al.
Human Immunology|January 23, 1998
The CCR5 deletion mutation fails to protect against multiple sclerosisB H Bennetts, S M Teutsch, M M Buhler, et al.
Human Immunology|August 10, 1999
The DRB1 Val86/Val86 genotype associates with multiple sclerosis in Australian patientsS M Teutsch, B H Bennetts, M M Buhler, et al.
Human Immunology|October 20, 1999
HLA-DMB gene and HLA-DRA promoter region polymorphisms in Australian multiple sclerosis patientsB H Bennetts, S M Teutsch, M M Buhler, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Medical Journal of Australia|July 5, 1993
HTLV-I in AustraliaR N Heard
The Medical Journal of Australia|May 17, 1993
New horizons in the treatment of multiple sclerosisR N Heard
International Clinical Psychopharmacology|July 1, 1986
Visual hallucinations due to indomethacin: a case reportL E Braddock, R N Heard
Immunogenetics|January 1, 1989
An epitope on C4 beta light (L) chains detected by human anti-Rg; its relationship with beta chain polymorphism and MHC associationsT Robson, R N Heard, C M Giles
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2000
T cell receptor beta chain genotyping in Australian relapsing-remitting multiple sclerosis patientsM M Buhler, B H Bennetts, R N Heard, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|April 1, 1997
HLA-DR, -DQA1 and -DQB1 associations in Australian multiple sclerosis patientsG J Stewart, S M Teutsch, M Castle, et al.
Journal of Neuroimmunology|June 1, 1995
TAP2 polymorphisms in Australian multiple sclerosis patientsB H Bennetts, S M Teutsch, R N Heard, et al.
Human Immunology|January 23, 1998
The CCR5 deletion mutation fails to protect against multiple sclerosisB H Bennetts, S M Teutsch, M M Buhler, et al.
Human Immunology|August 10, 1999
The DRB1 Val86/Val86 genotype associates with multiple sclerosis in Australian patientsS M Teutsch, B H Bennetts, M M Buhler, et al.
Human Immunology|October 20, 1999
HLA-DMB gene and HLA-DRA promoter region polymorphisms in Australian multiple sclerosis patientsB H Bennetts, S M Teutsch, M M Buhler, et al.
Pageof 2